qDSA Blood Flow Measurement in Patients Undergoing Transarterial Embolization (TAE) of the Liver
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The purpose of this research is to evaluate a new technique, quantitative digital subtraction angiography (qDSA), to measure blood flow during liver embolization procedures. Liver transarterial embolization is a way of treating liver tumors by blocking blood flow to it. The qDSA technique could help doctors ensure the blood flow to the tumor is decreased by the right amount by calculating blood flow before, during, and after the procedure. Up to 20 participants will be enrolled for 1 study visit and data collection for up to 6 months.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Give voluntary, written informed consent to participate in this study and willing to comply with study-related evaluation and procedure schedule
Locations
United States
Wisconsin
UW Hospital and Clinics
RECRUITING
Madison
Contact Information
Primary
Radiology Coordinators
Radstudy@uwhealth.org
608-282-8349
Time Frame
Start Date: 2025-03-13
Estimated Completion Date: 2026-03
Participants
Target number of participants: 20
Treatments
Experimental: Participants Undergoing TAE of the Liver
Related Therapeutic Areas
Sponsors
Leads: University of Wisconsin, Madison
Collaborators: Siemens Medical Solutions